S ubsets of CD4
ϩ T cells, Th1 and Th2, are differentiated after Ag recognition from naive T cells, which are influenced by cytokines and surface molecules of APCs (1) (2) (3) . However, recent studies indicate that several chemical mediators, hormones, and neuropeptides are also important factors in determining the Th1/Th2 balance and the characters of immune responses (4 -7). PGE 2 is one of the well-known factors that influence Th1/Th2 activation, and is produced by APCs such as macrophages and dendritic cells. PGE 2 preferentially down-regulates IL-12R expression, and inhibits the differentiation of Th1 (8 -10) . PGE 2 also suppresses LPS-induced IL-12 production by macrophages and dendritic cells (11) (12) , and PGE 2 derived from APCs down-regulates IFN-␥ production by T cells (13) (14) . In B cell function, PGE 2 enhances IgE production of IL-4-and LPSstimulated B cells in vitro (15) . Recently, we reported that PGE 2 preferentially enhances Th2-type chemokine, macrophage-derived chemokine (CC chemokine ligand 22), production by APCs (16) . These reports show that the effects of PGE 2 almost suppress Th1-related immune responses and augment Th2-related immune responses, which is similar to the function of IL-4 in immune responses. PGE 2 is synthesized by three sequential steps (17) . First, arachidonic acid is liberated from membrane phospholipids by the action of cytosolic phospholipase A 2 (PLA 2 3 ; cPLA 2 ) or secretory PLA 2 (sPLA 2 ) isozymes. Next, released arachidonic acid is converted to PGH 2 by two cyclooxygenase (COX) isoforms, COX-1 and COX-2. Finally, PGH 2 is converted to PGE 2 by cytosolic PGE synthase (cPGES) and microsomal PGE synthase (mPGES) (18 -19) . Each enzyme is important for the biosynthesis of PGE 2 in various cells.
Genetic background is also important in the balance of Th1/Th2 differentiation in mice (20 -23) . In general, BALB/c mice easily induce Th2 responses after infection or immunization, such as Leishmania major (24 -26) . One of the mechanisms to induce Th2 response in BALB/c mice is the participation of IL-4, which is rapidly and abundantly produced by L. major infection and induces selective loss of IL-12R expression and IFN-␥ production (27) (28) (29) (30) (31) (32) . However, APCs such as dendritic cells and macrophages also influence Th differentiation by producing IL-12 and IFN-␥. Previously, we reported that splenic APCs from BALB/c mice have a greater sensitivity to the suppressive effect of PGE 2 (14) . Furthermore, we showed that the expressions of STAT4 and IFN-␥ were reduced in macrophages from BALB/c mice (33) . These results suggest that macrophages play an important role in the strain difference in Th1/Th2 activation.
In this study, we show evidence that macrophages from BALB/c mice produce greater amount of PGE 2 than ones from any other strain of mice. PGE 2 from BALB/c macrophages strongly suppress the production of IL-12 from macrophages themselves and of IFN-␥ from T cells. The strain difference in PGE 2 production by macrophages is due to a differential expression of sPLA 2 and mPGES, initial and terminal enzymes of arachidonate cascade, respectively, but not of COX-2. These results suggest that sPLA 2 and mPGES are novel therapeutic targets in the control of Th1/Th2 activation and Th2-related diseases.
Materials and Methods

Mice
Female A/J, AKR/N, BALB/c, CBA/N, C3H/HeN, C57BL/6, and DBA/2 mice (7-8 wk old) were purchased from Japan SLC (Shizuoka, Japan) or Charles River Japan (Yokohama, Japan). These mice were maintained in the Laboratory Animal Research Center at the University of Occupational and Environmental Health under specific pathogen-free conditions. All animal experiments were performed according to the guidelines for the care and use of animals approved by the University of Occupational and Environmental Health.
Reagents PGE 2 , indomethacin, arachidonic acid, anti-COX-1 Ab, anti-COX-2 Ab, anti-mPGES Ab, and anti-cPGES Ab were purchased from Cayman Chemicals (Ann Arbor, MI). Anti-CD3 Ab was purchased from BioSource International (Camarillo, CA). [5,6,8,9,11,12,14,15- 3 H]Arachidonic acid (sp. act. 200 Ci/mmol) and HRP-conjugated anti-rabbit Ig were purchased from Amersham Biosciences (Uppsala, Sweden). LPS (Escherichia coli serotype 055:B5) was purchased from Sigma-Aldrich (St. Louis, MO). EP4 antagonist (L-161982) was kindly donated by Dr. R. Young (Merck Frosst, Quebec, Canada) (34 -35) .
Preparation of cells
Peritoneal exudate cells were harvested 3 days after i.p. injection of 2 ml of 4% thioglycolate broth (Eiken, Tokyo, Japan), and cultured in an RPMI 1640 medium (Nissui Pharmaceutical, Tokyo, Japan) supplemented with 10% FBS (BioWhittaker, Walkersville, MD), 2 mM glutamine, 50 U/ml penicillin, and 50 g/ml streptomycin (all from Life Technologies, Rockville, MD) at 37°C for 2 h. Nonadherent cells were vigorously washed off with warm HBSS four times, and adherent cells were used as macrophages. The purity of macrophages was Ͼ95% F4/80 and Mac-1 positive as determined by flow cytometry. CD4 ϩ T cells were purified from spleen cells by MACS (Miltenyi Biotec, Bergisch-Gladbach, Germany) according to the manufacturer's procedures, and the purity of cells was Ͼ95% CD4 ϩ cells. Mac-1 ϩ cells from spleen cells were sorted by MACS, and used as splenic macrophages, whose purity was Ͼ90%.
In vitro stimulation of cells
Peritoneal macrophages (5 ϫ 10 5 /ml/well) and splenic macrophages (1 ϫ 10 6 /ml/well) from several strains of mouse were seeded into 24-well plates (Falcon 3047; BD Biosciences, Franklin Lakes, NJ). Cells were pretreated with or without indomethacin (1 M) or EP4 antagonist (0.1ϳ10 M) for 5 h, and then stimulated with LPS (1 g/ml) for an additional 24 h. Cellfree culture supernatants were collected and used for cytokine or PGE 2 assay as described below. In some experiments, arachidonic acid (0.3ϳ30 M) was added at the time of LPS stimulation. For Western blotting and mRNA analysis, macrophages (4 ϫ 10 6 /3 ml/well) from BALB/c and C57BL/6 mice were seeded into 6-well plates (Falcon 3046). Cells were stimulated with LPS for 6 -18 h, and used for the assay of Western blotting and RT-PCR as described below. For the assay of T-macrophage interaction, macrophages (1 ϫ 10 5 /250 l/well) from BALB/c and C57BL/6 mice were seeded in 48-well plates (Falcon 3078), and treated with or without 1 M of indomethacin or EP4 antagonist for 5 h. After treatments, CD4 ϩ T cells from C3H/HeN mice (1 ϫ 10 6 /250 l/well) were added to each well, and stimulated with LPS (1 g/ml), anti-CD3 Ab (1 g/ml), or LPS plus anti-CD3 Ab for an additional 24 h. Cell-free supernatants were collected, and used for IFN-␥ assay as described below. mRNA analysis mRNA expression was detected by RT-PCR as described previously (33) . The sequence of the sense and antisense primers, product size, and the number of PCR cycles were as follows: ␤-actin, 5Ј-ACCAACTGGGAC GACATGGAGAA-3Ј and 5Ј-GTGGTGGTGAAGCTGTAGCC-3Ј, 380 bp, 22 cycles; EP4, 5Ј-CGTAGTATTGTGCAAGTCGC-3Ј and 5Ј-GGC GATGAGTAAGATGACCA-3Ј, 388 bp, 34 cycles; sPLA 2 type IIA, 5Ј-CAGTTTGGGGAAATGATTCGGC-3Ј and 5Ј-GAAACATTCAGCGGC GGCTTTA-3Ј, 289 bp, 36 cycles; sPLA 2 type V, 5Ј-CAGGGGGCTTGCTA GAACTCAA-3Ј and 5Ј-AAGAGGGTTGTAAGTCCAGAGG-3Ј, 329 bp, 30 cycles; and cPLA 2 , 5Ј-TGTTCAACAGAGTTTTGG-3Ј and 5Ј-AACA GAGCAACGAGATGG-3Ј, 983 bp, 34 cycles. PCR conditions of ␤-actin, EP4, and cPLA 2 were 94°C for 1 min, 55°C for 1 min, and 72°C for 2 min, and those of sPLA 2 type IIA and sPLA 2 type V were 94°C for 1 min, 58°C for 1 min, and 72°C for 1 min and 20 s. Each cycle is four or five cycles below the maximum amplification, which is the linear part of the increase of PCR products, as determined by a preliminary experiment.
Cytokine and PGE 2 assay
IFN-␥ was determined by a standard ELISA as described previously (14) . TNF was determined by cytotoxic assay using L929 cells by the method of Flick and Gifford (36) . IL-12p70 was measured using Cytoscreen immunoassay (BioSource International) according to the manufacturer's protocol. PGE 2 was measured using STAT-PGE 2 enzyme immunoassay kit (Cayman Chemicals) according to the manufacturer's protocol.
Western blot analysis
Cells were lysed on ice with 100 l of Laemmli sample buffer solution. Obtained samples were boiled for 5 min, electrophoresed by 7% (for COX-2) or 15% (for cPGES and mPGES) SDS-PAGE, transferred to polyvinylidene difluoride membrane (Bio-Rad, Hercules, CA), and blotted with anti-COX-2, anti-cPGES, or anti-mPGES Ab (1/1000), and HRP-conjugated secondary Ab (1/2000). The reactive bands were visualized with Lumi-Light PLUS Western blotting substrate (Roche Diagnostics, Indianapolis, IN) as a substrate and Fluorochem (Alpha Innotech, San Leandro, CA) as a detector. For the assessment of protein concentrations of samples, cells were lysed with Nonidet P-40 lysis buffer (20 mM Tris-HCl (pH 7.5), 150 mM NaCl, and 1% Nonidet P-40). Protein concentrations were determined by a Bio-Rad protein assay standardized with BSA.
Arachidonic acid release
Macrophages were seeded into a 24-well plate at 2.5 ϫ 10 5 /400 l/well in an RPMI containing 2% FBS, and labeled with [
3 H]arachidonic acid (1 Ci/ml) for 4 h. After washing four times, the medium was replaced with 250 l of fresh medium, and the cells were cultured in the presence or absence of LPS for 5 h. Then, 125 l of culture supernatants were collected, and the amount of released arachidonic acid was measured by a scintillation counter (Aloka, Tokyo, Japan). Remaining cells were lysed with 250 l of 1% Triton X-100, and the radioactivities of lysed cells were measured for the total radioactivity incorporated. The amount of arachidonic acid release was expressed as the percentage of release, which was calculated as follows: percentage of release of arachidonic acid ϭ ((released radioactivity)/(released radioactivity ϩ total radioactivity incorporated)) ϫ 100.
Statistical analysis
All experiments were repeated at least three times, and some representative results are shown in figures. Statistical analyses were performed between BALB/c and C57BL/6 mice using Student's t test. A confidence level of Ͻ0.05 was considered significant (37) .
Results
Macrophages from BALB/c mice produce greater amounts of PGE 2 than macrophages from other strains of mice
At first, we investigated the capacity of PGE 2 production by macrophages from several mouse strains. After LPS stimulation, macrophages from BALB/c mice produced greater amounts of PGE 2 than cells from other mouse strains (Fig. 1A) . Because C57BL/6 and BALB/c mice are important strains as the representative Th1-and Th2-dominant mice, respectively, we compared mainly these two strains in the following experiments. We performed the same experiment using splenic macrophages and found that splenic macrophages from BALB/c mice also produced greater amounts of PGE 2 (Fig. 1B) . These phenomena were not restricted to LPS stimulation, because similar results were obtained in Staphylococcus aureus Cowan I-stimulated macrophages from BALB/c and C57BL/6 mice (data not shown). These results indicate that PGE 2 production is augmented in BALB/c macrophages as compared with C57BL/6 macrophages.
PGE 2 -dependent autocrine and paracrine suppression of Th1 cytokine production by macrophages is much stronger in BALB/c mice
To study the role of PGE 2 produced by macrophages, first we assessed the capacity of Th1 cytokine production by macrophages from BALB/c and C57BL/6 mice. When macrophages were treated with indomethacin, a COX inhibitor, and stimulated with LPS, IL-12 and TNF productions were markedly increased in BALB/c macrophages, while only weak responses were observed in C57BL/6 macrophages ( Fig. 2) . Because it has been reported that the suppressive effect of Th1 cytokine by PGE 2 in macrophages is mainly mediated by the EP4 receptor (38), we performed the same experiments using an EP4 antagonist and obtained similar results, that is, EP4 antagonist significantly augmented IL-12 and TNF production in macrophages from BALB/c mice, but not in ones from C57BL/6 mice (Fig. 2) . We also assessed EP4 mRNA expression in macrophages by RT-PCR, and macrophages from both strains similarly expressed EP4 mRNA (Fig. 3) . The treatment with EP4 antagonist had no effect on PGE 2 production by macrophages (data not shown).
PGE 2 is also reported to suppress cytokine production by Th1 cells. Therefore, we next assessed the role of PGE 2 from macrophages in IFN-␥ production by T cells. Macrophages from BALB/c or C57BL/6 mice were cultured in the presence or absence of indomethacin or EP4 antagonist, and then allogenic CD4 ϩ T cells (from C3H/HeN mice) were added and stimulated with LPS, anti-CD3 Ab, or LPS plus anti-CD3 Ab. As shown in Fig. 4 , indomethacin-or EP4 antagonist-treated macrophages significantly enhanced T cell-derived IFN-␥ production after LPS-or LPS plus anti-CD3 Ab-stimulation as compared with nontreated macrophages. The degree of enhancement of IFN-␥ production is much stronger in macrophages from BALB/c mice, and only weak effects were observed in macrophages from C57BL/6 mice. T cells or macrophages alone did not produce detectable levels of IFN-␥ even after stimulation (data not shown). These results indicate that macrophage-derived PGE 2 has a suppressive effect on Th1 cytokine production by macrophages as an autocrine mechanism, and on IFN-␥ production by T cells as a paracrine mechanism. The autocrine and paracrine mechanisms of macrophage-dependent FIGURE 1. Macrophages from BALB/c mice produce greater amounts of PGE 2 than those from other strains of mice. Peritoneal macrophages (A) and splenic macrophages (B) from several strains of mice were stimulated with LPS (1 g/ml) for 18 h. Culture supernatants were collected, and the amount of PGE 2 was detected by enzyme immunoassay. ‫,ء‬ Significantly higher in BALB/c mice.
FIGURE 2.
Indomethacin and EP4 antagonist enhanced Th1-type cytokine production in BALB/c macrophages but not in C57BL/6 macrophages. Macrophages from BALB/c and C57BL/6 mice were pretreated with indomethacin (ind; 1 M) or EP4 antagonist (EP4A; 0.1ϳ10 M) for 6 h, and stimulated with LPS for an additional 18 h. Culture supernatants were collected, and the amounts of IL-12p70 (A) and TNF (B) in the culture supernatants were detected by ELISA or bioassay, respectively. ‫,ء‬ Significantly higher in BALB/c mice. suppression were much stronger in BALB/c mice, corresponding to the amount of PGE 2 .
COX-2 expression is not different between macrophages from BALB/c and C57BL/6 mice
It is known that COX-2 expression is closely linked with PGE 2 production in several cell types. We examined whether COX-2 expression in macrophages was different between BALB/c and C57BL/6 mice. As shown in Fig. 5 , COX-2 protein was not expressed in nonstimulated macrophages, and those expressions were equally augmented after LPS stimulation in macrophages from both mouse strains. This result indicates that the enhanced production of PGE 2 by BALB/c macrophages is not due to the difference in COX-2 expression.
Expression of sPLA 2 and release of arachidonic acid are linked with enhanced production of PGE 2 in BALB/c macrophages
It is known that arachidonic acid is a substrate for prostanoid synthesis, and the regulation of release of arachidonic acid is an initial step of the arachidonate cascade. We examined whether the release of arachidonic acid in macrophages was different between BALB/c and C57BL/6 mice. When cells were labeled with [ 3 H]arachidonic acid, radioactivities of incorporated arachidonic acid were almost the same between BALB/c and C57BL/6 macrophages. However, the release of arachidonic acid from macrophages was different. Macrophages spontaneously released arachidonic acid, and the release increased after LPS stimulation. Both spontaneous and LPSinduced release of arachidonic acid were greater in BALB/c macrophages than in C57BL/6 ones (Table I) .
Arachidonic acid is liberated from membrane glycerophospholipids by PLA 2 . It has been reported that cPLA 2 , sPLA 2 type IIA, and sPLA 2 type V play an important role in arachidonic acid release (39 -44) . Moreover, the C57BL/6 mouse has a natural defect ) from BALB/c and C57BL/6 mice were labeled with [ 3 H]arachidonic acid (1 Ci/ml) and washed. Macrophages were stimulated with LPS for 5 h, and the amount of released arachidonic acid and total radioactivities incorporated were counted. The percentages of release were calculated as follows: percentage of release of arachidonic acid ϭ (released radioactivity)/(released radioactivity ϩ total radioactivity incorporated) ϫ 100.
b Significantly higher in BALB/c mice.
in the sPLA 2 type IIA gene (42, 45) . Therefore, we examined the mRNA expression of these three types of PLA 2 families in macrophages from both strains. As shown in Fig. 6 , cPLA 2 mRNA was expressed in nonstimulated macrophages, and slightly up-regulated at 6 h after stimulation. However, expression was equal in both BALB/c and C57BL/6 mice. The expression of sPLA 2 type V mRNA was up-regulated after stimulation, and the expression level of mRNA was higher in BALB/c macrophages than in C57BL/6 ones, while the expression of sPLA 2 type IIA mRNA was not detected in any period. These results suggest that the release of arachidonic acid by macrophages is different between BALB/c and C57BL/6 mice, and one of the causes of the differential release of arachidonic acid by macrophages seems to be the differential expression of sPLA 2 type V.
The terminal enzyme of PGE 2 synthesis is also higher in BALB/ c macrophages
Next, we assessed whether the enhanced production of PGE 2 was due to the difference in the amount of released arachidonic acid in BALB/c macrophages. Macrophages from BALB/c and C57BL/6 mice were stimulated with LPS in the presence or absence of a large amount of arachidonic acid. The addition of arachidonic acid induced overproduction of PGE 2 , and IL-12 production was suppressed in a dose-dependent manner, corresponding to the amount of PGE 2 (Fig. 7) . However, contrary to our expectations, macrophages from BALB/c mice further produced greater amounts of PGE 2 with the addition of an excess amount (30 M) of arachidonic acid, and C57BL/6 mice did not reach the level of BALB/c mice. These results suggest that not only the greater release of arachidonic acid but also other factors relate to the enhanced production of PGE 2 in BALB/c macrophages. The final step of PGE 2 synthesis is a conversion of PGH 2 to PGE 2 by two PGE synthase isoforms, cPGES or mPGES (18 -19) . We assessed the expression of both types of PGES isoforms in macrophages from BALB/c and C57BL/6 mice. As shown in Fig.  8 , cPGES was constitutively expressed in non-and LPS-stimulated FIGURE 6. Expression of sPLA 2 type V mRNA, but not cPLA 2 mRNA, is greater in BALB/c macrophages than in C57BL/6 macrophages. A, Macrophages (4 ϫ 10 6 ) from BALB/c (B/c) and C57BL/6 (B6) mice were stimulated with LPS for the indicated periods, and then total RNA was extracted and the expression of PLA 2 mRNA was detected by RT-PCR. B, Relative amount of sPLA 2 type V expression normalized by ␤-actin. C, Relative amount of cPLA 2 expression normalized by ␤-actin. sPLA 2 type IIA was not detected.
FIGURE 7.
Exogeneous addition of arachidonic acid suppresses IL-12 production via enhanced production of PGE 2 . Macrophages (5 ϫ 10 5 /ml) from BALB/c and C57BL/6 mice were stimulated with LPS for 18 h in the presence or absence of arachidonic acid (0.3ϳ3 M), and the culture supernatants were collected. The amounts of PGE 2 (A) and IL-12p70 (B) in the culture supernatants were detected using enzyme immunoassay or ELISA, respectively. ‫,ء‬ Significantly higher than the group of LPS stimulation alone. †, Significantly suppressed from the group of LPS stimulation alone. A.A., Arachidonic acid. macrophages, and this expression was equal in both BALB/c and C57BL/6 mice. However, the expression of mPGES was up-regulated after LPS stimulation, and it was greater in BALB/c macrophages than in C57BL/6 macrophages.
These results indicate that the increased production of PGE 2 by BALB/c macrophages is regulated by two steps: greater release of arachidonic acid, which is caused by a greater expression of sPLA 2 type V, the initial step of arachidonate cascade, and greater expression of mPGES, the terminal enzyme of PGE 2 synthesis.
Discussion
The mechanisms that induce Th2-dominant responses in BALB/c mice remain to be clarified completely. Several reports indicate that the mechanisms of Th2 polarization in BALB/c mice are due to a greater production of IL-4 from T cells themselves. However, some reports show that macrophages from BALB/c mice have some functional abnormalities (33, 46 -49) . We have studied the mechanisms of Th2 polarization in BALB/c mice from the standpoint of macrophage functions (14, 16) . In this study, we showed evidence that PGE 2 production was enhanced in macrophages from BALB/c mice and that it played a role in the suppression of Th1 activation. PGE 2 suppresses Th1 responses and consequently activates Th2 responses at various steps. Representative effects of PGE 2 in the immune responses are 1) a selective suppression of cytokine production by Th1 and an inhibition of Th1 differentiation (8 -9), 2) a suppression of Th1-activating cytokine production by APCs (11) (12) , and 3) an enhanced production of IgE by B cells (15) . In a previous report, we found that PGE 2 up-regulated Th2-type chemokine production but suppressed Th1-type chemokine production by APCs (16) , and indicated that PGE 2 played a role in the determination of the Th1/Th2 balance at both the induction and effector phases of the immune response by modulating cytokine and chemokine production. Furthermore, we reported that BALB/c spleen cells had a greater sensitivity to the suppressive effect of PGE 2 , while there was no significant difference in PGE 2 production by spleen cells from BALB/c, C3H/HeN, and C57BL/6 mice (14) . We used whole spleen cells in our previous experiments. However, we used highly purified macrophages in this study. The differences in the amount of PGE 2 produced seem to depend on the purity of participating cells, and macrophages from BALB/c mice have a capacity to produce a greater amount of PGE 2 than cells from C57BL/6 mice ( Fig. 1) .
Not only COX but also several other molecules participate in PGE 2 synthesis. We found the enhanced expression of sPLA 2 type V and mPGES in BALB/c macrophages (Figs. 6 and 8) . In general, the expression level of COX has been the focus of PGE 2 synthesis. However, the regulation or the cooperation of all these enzymes is important in PGE 2 biosynthesis. In our study, macrophages from BALB/c and C57BL/6 mice expressed similar levels of COX-2 protein (Fig. 5) . In fact, there are many reports that most tumor cells overexpressed COX-2 (50). However, we found that not all tumor cells expressed COX-2 to produce PGE 2 (data not shown). The first step of PGE 2 synthesis is the liberation of arachidonic acid from the membrane phospholipids by PLA 2 . Especially cPLA 2 , sPLA 2 type IIA, and sPLA 2 type V play a pivotal role in the release of arachidonic acid as reported by several investigators (39 -44) . In our experiments, macrophages did not express sPLA 2 type IIA, and they expressed more sPLA 2 type V in BALB/c macrophages than in C57BL/6 macrophages (Fig. 6) . Balboa et al. (39) and Reddy et al. (51) reported that macrophage cell lines and cultured mast cells expressed only sPLA 2 type V, which was related to the release of arachidonic acid. These reports are consistent with our study, and we suggest that the regulation of sPLA 2 type V expression is important in the release of arachidonic acid. PGES is a terminal enzyme of PGE 2 biosynthesis, and two isoforms of PGES have been reported: cPGES, which is constitutively expressed like COX-1, and mPGES, which is inducible. We also obtained the same results showing that cPGES is constitutive and mPGES is inducible, and the strain differences were observed in mPGES expression, but not in cPGES expression (Fig. 8) . These results indicate that the enhanced production of PGE 2 in BALB/c macrophages is due to the greater expression of sPLA 2 type V and mPGES, but not of COX-2. We suggest that sPLA 2 type V and mPGES are novel therapeutic targets for the regulation of PGE 2 production in allergic diseases.
It is known that one of the mechanisms of Th2 activation by PGE 2 depends on the intracellular accumulation of cAMP (17) . There are four major PGE 2 receptor subtypes of G protein-linked receptor families called EP1, EP2, EP3, and EP4, and, of these, EP2 and EP4 receptors are coupled to adenylate cyclase (17) . A recent report indicated that EP4 was mainly related to the suppression of Th1 cytokines in macrophages, and EP2 was linked to the T cell activation (38) . We found that EP4 antagonist strongly increased IL-12 and TNF production by macrophages from BALB/c mice but not by those from C57BL/6 mice, similar to the effects of treatment with a COX inhibitor, indomethacin (Fig. 2) . These results indicate that PGE 2 produced by macrophages suppresses IL-12 and TNF production via the EP4 receptor in an autocrine manner (Fig. 2) . Moreover, we also found that macrophages treated with an EP4 antagonist enhanced T cell-derived IFN-␥ production by interfering with the paracrine suppression of PGE 2 (Fig.  4) . Thus, the EP4 antagonist works as an effective enhancer of Th1 activation by modulating macrophage-derived IL-12 production. Now, we are investigating the manipulation of the Th1/Th2 balance using EP4 antagonist in vivo.
There are also several reports that PGE 2 production is enhanced in Th2-related diseases. Monocytes from patients with atopic dermatitis produce a greater amount of PGE 2 than cells from normal donors, and the addition of COX inhibitor reverses the suppressive effect of IFN-␥ by PGE 2 produced from PBMC (52) (53) . In a murine model of allergic airway inflammation, a greater amount of PGE 2 is detected in the bronchoalveolar lavage fluid (54) . In Leishmania infection, cells from infected mice produce more PGE 2 in BALB/c mice than in C57BL/6 mice, and the expression of COX-2 is observed in BALB/c mice, but not in C57BL/6 mice (55) (56) . In a murine model of endotoxin liver injury, PGE 1 acts as a protective factor by inducing Th2 responses (57) . These reports indicate that PGE 2 plays an important role in the control of diseases by regulating Th1/Th2 balance. Therefore, we suggest that the modulation of PLA 2 , COX, and PGES, or receptor antagonists for PGE 2 , are promising therapeutic targets for several diseases.
In conclusion, we found that macrophages from BALB/c mice produced greater amounts of PGE 2 than cells from other strains of mice. The greater amount of PGE 2 produced by BALB/c macrophages strongly suppressed macrophage-derived IL-12 and T cellderived IFN-␥ production by autocrine and paracrine manners, and induced Th2-dominant immune responses. The increased production of PGE 2 by BALB/c macrophages is due to the greater expression of sPLA 2 type V and mPGES, but not COX-2. Thus, macrophages from Th2-dominant BALB/c mice have different functional characters regarding PGE 2 production as compared with other strains of mice. We previously reported the reduced expression of STAT4 and IFN-␥ in macrophages from BALB/c mice. Taking these studies together, we propose that the altered macrophage functions affect Th1/Th2 balance, and the modulation of macrophage functions will open a new way for the treatment of immunological diseases, such as autoimmune or allergic diseases.
